Outcomes: In this pilot proposal, 100 patients at three centers will be evaluated to test the feasibility of conducting this study and to assess the treatment effect of roflumilast to be able to power an appropriate definitive phase III multicenter trial. Our ultimate aims of the phase III trial will be: